{"title":"老年人唾液白细胞介素1- β浓度与睡眠质量的关系","authors":"Vanessa Ibáñez-Del Valle, Maria Luisa Ballestar-Tarín, Mayra Alejandra Mafla-España, Omar Cauli, Rut Navarro-Martínez","doi":"10.1177/10998004231181347","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Poor sleep quality is prevalent in older people and impairs their quality of life. Various studies show an association between sleep disorders and altered levels of inflammatory cytokines. The cytokine IL-1β has been shown to display both somnogenic and insomnia-promoting effects in experimental animals. Objectives: to evaluate the relationship between insomnia and salivary IL-1β concentration and the role of associated factors such as the symptoms of depression, use of hypnotics, intake of caffeinated beverages, smoking, and alcohol use in older individuals. An analytical, cross-sectional, observational research was carried out with a population of community-dwelling individuals over 60 years of age in Valencia (Spain). Sleep quality was measured with the Athens insomnia scale (AIS) and depressive symptoms with Geriatric Depression Scale (GDS). Results: 287 individuals participated in the study (mean age 74.08 years (76.7% women). 41.5% of the participants had insomnia, 36.9% took drugs for sleep problems, and 32.4% had relevant depressive symptoms. There was a significant inverse correlation between the IL-1β and total AIS score (rho = -0.302, <i>p</i> < 0.001), the sleep difficulty subdomain (rho = -0.259, <i>p</i> < 0.001), and the daytime sleepiness subdomain (rho = -0.322, <i>p</i> < 0.001). No significant correlation was observed between GDS and salivary IL-1β concentration. The IL-1β concentration was significantly lower in individuals taking drugs for sleeping compared with those not taking those drugs (1.11 ± 0.09 and 1.48 ± 0.08, respectively; <i>p</i> = 0.001). Regarding the AIS score, there was no significant difference in marital status, smoking, or the number of cups of tea or cola drinks, but there was a significant association with alcohol intake (<i>p</i> = 0.019) and in the number of daily intakes of coffee (<i>p</i> = 0.030). The receiver operating characteristic (ROC) curve analysis of IL-1β for diagnosis of moderate-severe insomnia showed an area under the curve (AUC) value of 0.78 (95% confidence interval 0.71-0.85). At the cut-off of 0.83 pg/µL of Il-1β, it had a sensitivity of 70.3% and a specificity of 69.8%.</p>","PeriodicalId":8997,"journal":{"name":"Biological research for nursing","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Salivary Interleukin 1-Beta Concentration Associates With Sleep Quality in Older Individuals.\",\"authors\":\"Vanessa Ibáñez-Del Valle, Maria Luisa Ballestar-Tarín, Mayra Alejandra Mafla-España, Omar Cauli, Rut Navarro-Martínez\",\"doi\":\"10.1177/10998004231181347\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background:</b> Poor sleep quality is prevalent in older people and impairs their quality of life. Various studies show an association between sleep disorders and altered levels of inflammatory cytokines. The cytokine IL-1β has been shown to display both somnogenic and insomnia-promoting effects in experimental animals. Objectives: to evaluate the relationship between insomnia and salivary IL-1β concentration and the role of associated factors such as the symptoms of depression, use of hypnotics, intake of caffeinated beverages, smoking, and alcohol use in older individuals. An analytical, cross-sectional, observational research was carried out with a population of community-dwelling individuals over 60 years of age in Valencia (Spain). Sleep quality was measured with the Athens insomnia scale (AIS) and depressive symptoms with Geriatric Depression Scale (GDS). Results: 287 individuals participated in the study (mean age 74.08 years (76.7% women). 41.5% of the participants had insomnia, 36.9% took drugs for sleep problems, and 32.4% had relevant depressive symptoms. There was a significant inverse correlation between the IL-1β and total AIS score (rho = -0.302, <i>p</i> < 0.001), the sleep difficulty subdomain (rho = -0.259, <i>p</i> < 0.001), and the daytime sleepiness subdomain (rho = -0.322, <i>p</i> < 0.001). No significant correlation was observed between GDS and salivary IL-1β concentration. The IL-1β concentration was significantly lower in individuals taking drugs for sleeping compared with those not taking those drugs (1.11 ± 0.09 and 1.48 ± 0.08, respectively; <i>p</i> = 0.001). Regarding the AIS score, there was no significant difference in marital status, smoking, or the number of cups of tea or cola drinks, but there was a significant association with alcohol intake (<i>p</i> = 0.019) and in the number of daily intakes of coffee (<i>p</i> = 0.030). The receiver operating characteristic (ROC) curve analysis of IL-1β for diagnosis of moderate-severe insomnia showed an area under the curve (AUC) value of 0.78 (95% confidence interval 0.71-0.85). At the cut-off of 0.83 pg/µL of Il-1β, it had a sensitivity of 70.3% and a specificity of 69.8%.</p>\",\"PeriodicalId\":8997,\"journal\":{\"name\":\"Biological research for nursing\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biological research for nursing\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/10998004231181347\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/6/2 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"NURSING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biological research for nursing","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10998004231181347","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/2 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"NURSING","Score":null,"Total":0}
引用次数: 0
摘要
背景:睡眠质量差是老年人普遍存在的问题,影响了他们的生活质量。各种研究表明,睡眠障碍和炎性细胞因子水平的改变之间存在关联。细胞因子IL-1β在实验动物中显示出促睡眠和促失眠的作用。目的:评估老年人失眠与唾液IL-1β浓度之间的关系,以及抑郁症状、使用催眠药、摄入含咖啡因饮料、吸烟和饮酒等相关因素的作用。对西班牙瓦伦西亚60岁以上社区居民进行了一项分析性、横断面性、观察性研究。用雅典失眠症量表(AIS)测量睡眠质量,用老年抑郁量表(GDS)测量抑郁症状。结果:287人参与研究,平均年龄74.08岁(76.7%为女性)。41.5%的人失眠,36.9%的人服用药物治疗睡眠问题,32.4%的人有相关的抑郁症状。IL-1β与AIS总分(rho = -0.302, p < 0.001)、睡眠困难子域(rho = -0.259, p < 0.001)、白天嗜睡子域(rho = -0.322, p < 0.001)呈显著负相关。GDS与唾液IL-1β浓度无显著相关。服用安眠药组IL-1β浓度显著低于未服用安眠药组(分别为1.11±0.09和1.48±0.08);P = 0.001)。关于AIS评分,婚姻状况、吸烟、喝茶或可乐饮料的杯数没有显著差异,但与酒精摄入量(p = 0.019)和每日咖啡摄入量(p = 0.030)有显著关联。IL-1β诊断中重度失眠症的受试者工作特征(ROC)曲线分析显示,曲线下面积(AUC)为0.78(95%可信区间为0.71 ~ 0.85)。在Il-1β浓度为0.83 pg/µL的临界值下,灵敏度为70.3%,特异性为69.8%。
Salivary Interleukin 1-Beta Concentration Associates With Sleep Quality in Older Individuals.
Background: Poor sleep quality is prevalent in older people and impairs their quality of life. Various studies show an association between sleep disorders and altered levels of inflammatory cytokines. The cytokine IL-1β has been shown to display both somnogenic and insomnia-promoting effects in experimental animals. Objectives: to evaluate the relationship between insomnia and salivary IL-1β concentration and the role of associated factors such as the symptoms of depression, use of hypnotics, intake of caffeinated beverages, smoking, and alcohol use in older individuals. An analytical, cross-sectional, observational research was carried out with a population of community-dwelling individuals over 60 years of age in Valencia (Spain). Sleep quality was measured with the Athens insomnia scale (AIS) and depressive symptoms with Geriatric Depression Scale (GDS). Results: 287 individuals participated in the study (mean age 74.08 years (76.7% women). 41.5% of the participants had insomnia, 36.9% took drugs for sleep problems, and 32.4% had relevant depressive symptoms. There was a significant inverse correlation between the IL-1β and total AIS score (rho = -0.302, p < 0.001), the sleep difficulty subdomain (rho = -0.259, p < 0.001), and the daytime sleepiness subdomain (rho = -0.322, p < 0.001). No significant correlation was observed between GDS and salivary IL-1β concentration. The IL-1β concentration was significantly lower in individuals taking drugs for sleeping compared with those not taking those drugs (1.11 ± 0.09 and 1.48 ± 0.08, respectively; p = 0.001). Regarding the AIS score, there was no significant difference in marital status, smoking, or the number of cups of tea or cola drinks, but there was a significant association with alcohol intake (p = 0.019) and in the number of daily intakes of coffee (p = 0.030). The receiver operating characteristic (ROC) curve analysis of IL-1β for diagnosis of moderate-severe insomnia showed an area under the curve (AUC) value of 0.78 (95% confidence interval 0.71-0.85). At the cut-off of 0.83 pg/µL of Il-1β, it had a sensitivity of 70.3% and a specificity of 69.8%.
期刊介绍:
Biological Research For Nursing (BRN) is a peer-reviewed quarterly journal that helps nurse researchers, educators, and practitioners integrate information from many basic disciplines; biology, physiology, chemistry, health policy, business, engineering, education, communication and the social sciences into nursing research, theory and clinical practice. This journal is a member of the Committee on Publication Ethics (COPE)